A number of proteins has been explored as potential fluid biomarkers for frontotemporal dementia and amyotrophic lateral sclerosis, particularly those relating to frontotemporal dementia/amyotrophic lateral sclerosis brain pathology, e.g. TDP-43, tau, C9ORF72 or SOD1. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.